Factor VIII Structure and Function

Philip J Fay

doi:10.1055/s-0038-1646161

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1993; 70(01): 063-067
DOI: 10.1055/s-0038-1646161

State-of-the-Art Lecture

Hemophilia

Schattauer GmbH Stuttgart

Factor VIII Structure and Function

Philip J Fay

Department of Medicine, University of Rochester School of Medicine & Dentistry, Rochester, New York, USA

› Institutsangaben

Abstract

als PDF herunterladen

PDF (1776 kb)

Referenzen

References
1 Weiss HJ, Sussman II, Hoyer LW. Stabilization of factor VIII in plasma by the von Willebrand factor. J Clin Invest 1977; 60: 390-404
2 Kaufman RJ, Wasley LC, Dorner AJ. Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. J Biol Chem 1988; 263: 6352-6362
3 Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. 1990; Blood 76: 1-16
4 van Dieijen G, Tans G, Rosing J, Hemker HC. The role of phospholipid and factor VIIIa in the activation of bovine factor Xa. J Biol Chem 1981; 256: 3433-3442
5 Mutucumarana VP, Duffy EJ, Lollar P, Johnson AE. The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor Villa. J Biol Chem 1992; 267: 17012-17021
6 Wood WI, Capon DJ, Simonsen CC, Eaton DL, Gitschier J, Keyt B, Seeburg PH, Smith DH, Hollingshead P, Wion KL. Expression of active human factor VIII from recombinant DNA clones. Nature 1984; 312: 330-337
7 Toole JJ, Knopf JL, Wozney JM, Sultzman LA, Beucker JL, Pittman DD, Kaufman RJ, Brown E, Shoemaker C, Orr EC. Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature 1984; 312: 342-347
8 Vehar GA, Keyt B, Eaton D, Rodriguez H, O'Brien DP, Rotblat F, Oppermann H, Keck R, Wood WI, Harkins RN. Structure of human factor VIII. Nature 1984; 312: 337-342
9 Vehar G, Davie EW. Preparation and properties of bovine factor VIII. Biochemistry 1980; 19: 401-410
10 Fass DN, Knutson GJ, Katzmann JA. Monoclonal antibodies to porcine factor VIII coagulant and their use in the isolation of active coagulant protein. Blood 1982; 59: 594-600
11 Fulcher CA, Zimmerman TS. Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody. Proc Natl Acad Sci USA 1982; 79: 1648-1652
12 Rotblat F, O'Brien DP, O'Brien FJ, Goodall AH, Tuddenham EG. Purification of human factor VIII:C and its characterization by Western blotting using monoclonal antibodies. Biochemistry 1985; 24: 4294-4300
13 Andersson LO, Forsman N, Huang K, Larsen K, Lundin A, Pavlu B, Sandberg H, Sewerin K, Smart J. Isolation and characterization of human factor VIII: Molecular forms in commercial factor VIII concentration, cryoprecipitate, and plasma. Proc Natl Acad Sci USA 1986; 83: 2979-2983
14 Fay PJ, Anderson MT, Chavin SI, and Marder VJ. The heterodimeric structure of human factor VIII and changes produced by thrombin interaction. Biochim Biophys Acta 1986; 871: 268-278
15 Eaton D, Rodriguez H, Vehar G. Proteolytic processing of human factor VIII: Correlation of specific cleavage by thrombin, factor Xa and activation protein C with activity and inactivation of factor VIII coagulant activity. Biochemistry 1986; 25: 505-512
16 Hamer RJ, Koedam JA, Beeser-Visser NH, Sixma JJ. Human factor VIII: Purification from commercial factor VIII concentration, characterization, identification and radiolabeling. Biochim Biophys Acta 1986; 873: 356-366
17 Fay PJ, Smudzin TM. Characterization of the interaction between the A2 subunit and A1/A3-C1-C2 dimer in human factor Villa. J Biol Chem 1992; 267: 13246-13250
18 Esmon CT. The subunit structure of thrombin activated factor V. J Biol Chem 1979; 254: 964-973
19 Fay PJ. Reconstitution of human factor VIII from isolated subunits. Arch Biochem Biophys 1988; 262: 525-531
20 Nordfang O, Ezban M. Generation of active coagulation factor VIII from isolated subunits. J Biol Chem 1988; 263: 1115-1118
21 Toole JJ, Pittman DD, Orr EC, Murtha P, Wasley LC, Kaufman RJ. A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity. Proc Natl Acad Sci USA, 1986; 83: 5939-5942
22 Eaton DL, Wood WI, Eaton D, Hass PE, Hollingshead P, Wion K, Mather J, Lawn RM, Vehar GA, Gorman C. Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule. Biochemistry 1986; 25: 8343-8347
23 Mosesson MW, Fass DN, Lollar P, DiOrio JP, Parker CG, Knutson GJ, Hainfeld JF, Wall JS. Structural model of porcine factor VIII and factor VIIIa molecules based on scanning transmission electron microscope (STEM) images and STEM mass analysis. J Clin Invest 1990; 85: 1983-1990
24 Fowler WE, Fay PJ, Arvan D, and Marder VJ. Electron microscopy of human factor V and factor VIII: Correlation of morphology with domain structure and localization of factor V activation fragments. Proc Natl Acad Sci USA 1990; 87: 7648-7652
25 Fay PJ, Smudzin TM. Inter-subunit fluorescence energy transfer in human factor VIII. J Biol Chem 1989; 264: 14005-14010
26 Owen WG, Wagner RH. Anti-hemophilic factor: Separation of an active fragment following dissociation by salts or detergents. Thromb Diath Haemorrh 1982; 27: 502-515
27 Lollar P, Parker CG. Stoichiometry of the porcine factor VIII-von Willebrand factor association. J Biol Chem 1987; 262: 17572-17576
28 Andersson LO, Brown JE. Interaction of factor VIII-von Willebrand factor with phospholipid vesicles. Biochem J 1981; 100: 161-167
29 Nesheim M, Pittman DD, Giles AR, Fass DN, Wang JH, Slonosky D, Kaufman RJ. The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets. J Biol Chem 1991; 166: 17815-17820
30 Hamer RJ, Koedam JA, Beeser-Visser NH, Bertina RM, vanMourik JA, Sixma JJ. Factor VIII binds to von Willebrand factor via its M_r~80,000 light chain. Eur J Biochem 1987; 166: 37-43
31 Bloom JW. The interaction of rDNA factor VIII, factor VIII_des797-1562 and factor VIII_deS797-1562-derived peptides with phospholipid. Thromb Res 48: 439-448 1987;
32 Foster PA, Fulcher CA, Houghten RA, Zimmerman TS. An immunogenic region with residues Val¹⁶⁷⁰-Glu¹⁶⁸⁴ of factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factor. J Biol Chem 1988; 263: 5230-5234
33 Leyte A, van Schijndel HB, Niehrs C, Huttner WB, Verbeet MP, Mertens K, vanMourik JA. Sulfation of Tyr¹⁶⁸⁰ of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor. J Biol Chem 1990; 266: 740-746
34 Foster PA, Fulcher CA, Houghten RA, Zimmerman TS. Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phos-phatidylserine. Blood 1990; 75: 1999-2004
35 Leyte A, Verbeet MP, Brodniewicz-Probe T, vanMourik JA, Mertens K. The interaction between human blood coagulation factor VIII and von Willebrand factor: Characterization of a high affinity binding site on factor VIII. Biochem J 1989; 157: 679-683
36 Gilbert GE, Furie BC, Furie B. Binding of human factor VIII to phospholipid vesicles. J Biol Chem 1990; 265: 815-822
37 Lollar P, Knutson GJ, Fass DN. Activation of porcine factor VIII:C by thrombin and factor Xa. Biochemistry 1985; 24: 6056-6064
38 Pieters J, Lindhout T, Hemker HC. In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma. Blood 1989; 74: 1021-1024
39 Koedam JA, Hamer RJ, Besser-Visser NH, Bouma BN, Sixma JJ. The effect of von Willebrand factor on activation of factor VIII by factor Xa. Eur J Biochem 1990; 1898: 229-234
40 Bihoreau N, Sauger A, Yon JM, van de Pol H. Isolation and characterization of different activated forms of factor VIII. Eur J Biochem 1989; 185: 111-118
41 Hill-Eubanks DC, Parker CG, Lollar P. Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin. Proc Natl Acad Sci USA 1989; 86: 6508-6512
42 Hill-Eubanks DC, Lollar P. von Willebrand factor is a cofactor for thrombin-catalyzed cleavage of the factor VIII light chain. J Biol Chem 1990; 265: 17854-17858
43 Pittman DD, Kaufman RJ. Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII). Proc Natl Acad Sci USA 1988; 85: 2429-2433
44 Lollar P, Parker CG. Subunit structure of thrombin-activated porcine factor VIII. Biochemistry 1989; 28: 666-674
45 Fay PJ, Haidaris PJ, Smudzin TM. Human factor VIIIa subunit structure: Reconstitution of factor Villa from the isolated A1/A3-C1-C2 dimer and A2 subunit. J Biol Chem 1991; 266: 8957-8962
46 Lollar P, Parker CG. pH-dependent denaturation of thrombin-activated porcine factor VIII. J Biol Chem 1990; 265: 1688-1692
47 Lamphear BJ, Fay PJ. Factor IXa enhances reconstitution of factor VIIIa from isolated A2 subunit and A1/A3-C1-C2 dimer. J Biol Chem 1992; 267: 3725-3730
48 Hultin MB, Jesty J. Activation and inactivation of human factor VIII by thrombin: Effects of inhibitors of thrombin. Blood 1981; 57: 476-482
49 Rick ME, Hoyer LW. Thrombin activation of factor VIII: Effects of inhibitors. Br J Haematol 1977; 36: 585-597
50 Lollar P, Parker ET, Fay PJ. Coagulant properties of hybrid human/porcine factor VIII molecules. J Biol Chem 1992; 267: 23652-23657
51 Duffy EJ, Parker ET, Mutucumarana VP, Johnson AE, Lollar P. Binding of factor VIIa and factor VIII to factor IXa on phospholipid vesicles. J Biol Chem 1992; 267: 17006-17011
52 Lollar P, Knutson GJ, Fass DN. Stabilization of thrombin-activated porcine factor VIII:C by factor IXa phospholipid. Blood 1984; 63: 1303-1308
53 Lollar P, Fass DN. Inhibition of activated porcine factor IX by dan-syl-glutamyl-glycyl-arginyl-chloromethylketone. Arch Biochem Bio-phys 1984; 233: 438-446
54 O'Brien DP, Johnson D, Byfield P, Tuddenham EG. Inactivation of factor VIII by factor IXa. Biochemistry 1992; 31: 2805-1812
55 Lamphear BJ, Fay PJ. Proteolytic interactions of factor IXa with human factor VIII and factor VIIa. Blood 1992; 80: 3120-3126
56 Walker FJ, Fay PJ. Regulation of blood cogulation by the protein C system. FASEB J 1992; 6: 2562-2567
57 Fulcher CA, Gardiner JE, Griffin JH, Zimmerman TS. Proteolytic inactivation of human factor VIII procoagulant protein by activated protein C and its analogy with factor V. Blood 1984; 63: 486-489
58 Walker FJ, Chavin SI, Fay PJ. Inactivation of factor VIII by activated protein C and protein S. Arch Biochem Biophys 1987; 252: 322-328
59 Fay PJ, Smudzin TM, Walker FJ. Activated protein C catalyzed inactivation of human factor VIII and factor VIIIa: Identification of cleavage sites and correlation of proteolysis with cofactor activity. J Biol Chem 1991; 266: 20139-20145
60 Odegaard B, Mann KG. Proteolysis of factor Va by factor Xa and activated protein C. J Biol Chem 1987; 262: 11233-11238
61 Guinto ER, Esmon CT. Loss of prothrombin and factor Xa-factor Va interaction upon inactivation of factor Va by activated protein C. J Biol Chem 1984; 259: 13986-13992
62 Aly AM, Higuchi M, Kasper CK, Kazazian HH, Antonarakis SE, Hoyer LW. Hemophilia A due to mutations that create new N-glyco-sylation sites. Proc Natl Acad Sci USA 1992; 89: 4933-4937
63 Suzuki K, Stenflo J, Dahlback B, Theodorsson B. Inactivation of human coagulation factor V by activated protein C. J Biol Chem 1983; 258: 1914-1920
64 Fay PJ, Walker FJ. Inactivation of human factor VIII by activated protein C: Evidence that the factor VIII light chain contains the activated protein C binding site. Biochim Biophys Acta 1989; 994: 142-148
65 Krishnaswamy S, Williams EB, Mann KG. The binding of activated protein C to factor V and Va. J Biol Chem 1986; 261: 9684-9693
66 Walker FJ, Scandella D, Fay PJ. Identification of the binding site for activated protein C on the light chain of factor V and factor VIII. J Biol Chem 1990; 265: 1484-1489
67 Koedam JA, Meijers JCM, Sixma JJ, Bouma B. Inactivation of factor VIII by activated protein C: Cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest 1988; 82: 1236-1243
68 Fay PJ, Coumans JV, Walker FJ. von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation. J Biol Chem 1991; 266: 2172-2177
69 Walker JF, Sexton PW, Esmon CT. The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V. Biochim Biophys Acta 1979; 571: 333-342
70 Nesheim ME, Canfield WM, Kisiel W, Mann KG. Studies of the capacity of factor X to protect factor Va from inactivation by activated protein C. J Biol Chem 1982; 257: 1443-1447
71 Solymoss S, Tucker MM, Tracy PB. Kinetics of inactivation of membrane-bound factor Va by activated protein C. J Biol Chem 1988; 263: 14884-14890
72 Bertina RM, Cupers R, van Wijngaardon A. Factor IXa protects activated factor VIII against inactivation by activated protein C. Biochem Biophys Res Commun 1984; 125: 177-183
73 Rick ME, Esmon NL, Krizek DM. Factor IXa and von Willebrand factor modify the inactivation of factor VIII by activated protein C. J Lab Clin Med 1990; 115: 415-421